Replies to post #128935 on Biotech Values

[mcbio]

So is every large drug/biotech company.

True, but I thought it at least a little bit interesting that the article was specific that Roche is after smaller, as opposed to larger, acquisitions, which is germane to our discussion about whether or not Roche could be interested in ACHN down the road.

[JJM760]

Do you think that the kind and apparently generous folks over at Roche would be interested in an acquisition that would give them a nice little inroads into the CML market and a potentially ass-kicking ALK/EGFR inhibitor to boot?

Just asking :)